RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 116 filers reported holding RAPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $513,558 | -11.1% | 30,900 | 0.0% | 0.00% | – |
| Q2 2023 | $577,830 | +1.9% | 30,900 | 0.0% | 0.00% | – |
| Q1 2023 | $567,015 | -7.3% | 30,900 | 0.0% | 0.00% | – |
| Q4 2022 | $611,820 | -9.5% | 30,900 | +10.0% | 0.00% | – |
| Q3 2022 | $676,000 | +31.8% | 28,100 | 0.0% | 0.00% | – |
| Q2 2022 | $513,000 | -17.0% | 28,100 | 0.0% | 0.00% | – |
| Q1 2022 | $618,000 | -39.9% | 28,100 | +0.4% | 0.00% | – |
| Q4 2021 | $1,028,000 | +18.3% | 28,000 | 0.0% | 0.00% | – |
| Q3 2021 | $869,000 | -2.4% | 28,000 | 0.0% | 0.00% | – |
| Q2 2021 | $890,000 | +174.7% | 28,000 | +91.8% | 0.00% | – |
| Q1 2021 | $324,000 | +12.5% | 14,600 | 0.0% | 0.00% | – |
| Q4 2020 | $288,000 | -38.7% | 14,600 | 0.0% | 0.00% | – |
| Q3 2020 | $470,000 | +22.7% | 14,600 | +10.6% | 0.00% | – |
| Q2 2020 | $383,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |